Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The National Retina Institute (NRI) was a prominent clinical and research center specializing in vitreoretinal diseases, founded in 1989 by Dr. Bert M. Glaser. Based in the Baltimore, Maryland area, the institute provided advanced diagnostic and surgical treatments for conditions such as macular degeneration, diabetic retinopathy, and retinal detachment. NRI was also a significant clinical research site, participating in numerous multicenter trials for breakthrough ophthalmic therapies, including anti-VEGF agents. In recent years, it operated as part of the Eyecare Services Partners (ESP) network through the Katzen Eye Group. The institute officially ceased patient operations on January 1, 2025, with care transitioning to affiliated practices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Retina Institute.